Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
BGSF, Inc. Q4 2025 Earnings Call - Pivot Complete, Debt Cleared, PropTech Push Begins
BGSF closed a transformational year, selling its professional division, retiring all debt, returning capital via a $2.00 special dividend, and emerging as a debt-free, cash-strong company focused sole...
- Company completed sale of professional division in fiscal 2025, leaving BGSF as a pure property management staffing business.
- All outstanding debt was retired, the company is debt-free and reports a strong cash position following the divestiture.
- Board returned capital via a $2.00 per share special dividend and announced a $5 million share repurchase program; total buybacks to date equal 522,000 shares for about $2.4 million.
- +12 more takeaways
G-III Apparel Group Q4 & Fiscal 2026 Earnings Call - Portfolio Pivot: Own Brands Driving Margin Expansion as PVH Licenses Roll Off
G-III closed fiscal 2026 in the middle of a deliberate, painful pivot. Reported net sales were $771 million in Q4 and $2.96 billion for the year, pressured by the phased exit of large PVH licenses and...
- Portfolio pivot is now explicit: G-III is reshaping away from large PVH licenses (Calvin Klein, Tommy Hilfiger) toward owned brands and select new licenses.
- Top-line impact from exits: FY2027 sales guidance of ~$2.71 billion reflects an approximate $470 million reduction tied to the rolling-off PVH licenses.
- Own brands gaining scale: DKNY, Donna Karan, Karl Lagerfeld and Vilebrequin now represent ~60% of revenue, up from ~50% last year, and grew mid-single digits collectively in FY2026.
- +12 more takeaways
Pharming Group N.V. Q4 and Full Year 2025 Earnings Call - Joenja Accelerates, RUCONEST Keeps Cash Flowing as Company Turns Profitable
Pharming closed 2025 with clear proof of transformation, reporting double-digit revenue growth, a return to operating profitability, and stronger cash. RUCONEST remains a resilient cash engine in the ...
- Total revenues rose 27% in 2025 to EUR 376.1 million, with Q4 revenues of EUR 106.5 million.
- Pharming returned to operating profitability in 2025, reporting adjusted operating profit of EUR 36.4 million versus a loss of EUR 8.6 million in 2024.
- RUCONEST grew 26% year-over-year in 2025, with U.S. volume up about 20% for the year and Q4 global revenue up 9% versus prior year quarter.
- +11 more takeaways
Ollie's Bargain Outlet Q4 FY2025 Earnings Call - New growth algorithm: 10% unit growth, 2% comps, 50% FCF to buybacks
Ollie’s closed fiscal 2025 with a hard-charging quarter: record 86 store openings, Q4 comps +3.6%, and net sales of $779 million, up 17% year over year. Management says the business has reached an inf...
- Company announces a new long-term growth algorithm: roughly 10% annual unit growth, 2% comparable store sales, and a baseline annual gross margin target of 40.5%.
- Management commits to returning about 50% of free cash flow to shareholders via share repurchases, stepping up buybacks with an initial ~ $100 million repurchase plan built into guidance.
- Record 86 store openings in fiscal 2025, well above prior record of 50, with 75 store openings planned for 2026 and a goal to reach 1,300 stores long term; store count at year-end was 658 across 35 states.
- +11 more takeaways
Vivid Seats Q4 2025 Earnings Call - Cost Cuts and App Momentum Set Stage for 2026 Growth Despite Q4 GOV Decline
Vivid Seats reported a painful Q4 traffic reset, with marketplace GOV plunging to $581 million from $994 million a year ago, but the new leadership leaned into cost cuts and product work as a clear co...
- Q4 2025 marketplace GOV fell to $581 million, down from $994 million year-over-year, driven by weaker concert onsales, a tough World Series comp, and the loss of a large private label customer.
- Total marketplace orders declined 32% year-over-year in Q4, and average order size dropped to $329 from $380 in Q4 2024.
- Q4 2025 revenue was $127 million versus $200 million in the prior year; adjusted EBITDA for the quarter was $1 million, reflecting negative operating leverage on lower volumes.
- +13 more takeaways
TIC Solutions Q4 2025 Earnings Call - CEO Succession, $25M Synergies, and Margin Recovery
TIC Solutions closed 2025 as a combined $2.1 billion company and turned the page to a new leadership chapter, naming Ben Heraud CEO effective March 31, 2026. The combination with NV5 produced $312 mil...
- Planned CEO transition: Ben Heraud to become CEO on March 31, 2026, with outgoing CEO Tal Pizzey remaining on the board and advising through transition.
- Combined 2025 results: Revenue roughly $2.1 billion, adjusted EBITDA $312 million, adjusted EBITDA margin 14.8%.
- Q4 2025: Total revenue $508 million, adjusted EBITDA $76.4 million, adjusted EBITDA margin 15.0%, with margin expansion across I&M, CE, and Geo.
- +11 more takeaways
Vera Bradley Fourth Quarter Fiscal 2026 Earnings Call - Return to Profitability as Project Sunshine Gains Traction
Vera Bradley closed FY26 with the first profitable quarter in over a year, reporting Q4 net income of $2.5 million and clear sequential improvement across direct channels after aggressive product and ...
- Company named Ian Bickley permanent CEO and expanded Martin Layding’s role to Chief Operating and Financial Officer, signaling board confidence in Project Sunshine.
- Q4 consolidated revenue was $84.9 million, down from $86.4 million year-over-year, with Q4 net income of $2.5 million.
- Management reported EPS of $0.09 in prepared remarks; the CFO stated $0.009 per diluted share during the call, creating a noted discrepancy in the verbal figures.
- +14 more takeaways
Rapid Micro Biosystems Q4 2025 Earnings Call - Beat, Multisystem Wins and a Roadmap to 20% Gross Margin
Rapid Micro reported a solid Q4: revenue $11.3 million, up 37% year over year, and a record 16 Growth Direct system placements. The quarter was underpinned by big multisystem orders from Amgen and an ...
- Q4 revenue $11.3 million, up 37% year over year, a quarterly record for the company.
- Placed 16 Growth Direct systems in Q4; 2025 year-end placements totaled 190 systems, with 155 fully validated.
- Product revenue rose 78% in Q4 to $9.3 million, driven primarily by system placements; consumables grew 11% in Q4.
- +12 more takeaways
Village Farms International Q4 2025 Earnings Call - Step‑change in profitability as EU GMP exports and Netherlands ramp unlock value
Village Farms closed 2025 with a clear step change: record net income, materially stronger adjusted EBITDA and cash flow, driven by a sharp increase in international exports and the first full quarter...
- 2025 was a watershed year: company-reported net income from continuing operations of $21 million ($0.19/share) and a step-change in adjusted EBITDA and cash flow versus 2024, per management.
- Global cannabis sales grew about 70% year-over-year in 2025, helped by the Netherlands partial-year contribution and a surge in international exports.
- International export sales increased more than six-fold year-over-year, benefiting from Village Farms’ EU GMP certification and tighter foreign quality requirements that favor certified suppliers.
- +11 more takeaways
Alliance Laundry Q4 2025 Earnings Call - Record margins, heavy deleveraging, and conservative 2026 guide
Alliance Laundry closed its first full fiscal year as a public company with strong, largely organic growth, a record full year adjusted EBITDA margin of 25.5%, and material balance sheet repair. Full ...
- Full year 2025 revenue $1.7 billion, up 13% year over year, with Q4 revenue $435 million, up 10% year over year.
- Record full year adjusted EBITDA margin of 25.5%, Q4 adjusted EBITDA $107 million, or 24.5% of revenue, a 140 basis point improvement in Q4 profitability.
- Net leverage cut materially to 2.8x adjusted EBITDA at year-end, total debt $1.4 billion down from $2.1 billion at start of year, cash $123 million; deleveraging funded roughly equally by operations and IPO proceeds.
- +12 more takeaways